Market Overview

Deloitte Expands Life Sciences Solutions Suite with Acquisition of QSpace IT Quality and Compliance Validation Technology

Share:

Deloitte Expands Life Sciences Solutions Suite with Acquisition of QSpace IT Quality and Compliance Validation Technology

PR Newswire

NEW YORK, Aug. 27, 2018 /PRNewswire/ -- To expand its suite of information technology quality and compliance solutions for life sciences organizations, Deloitte has acquired QSpace, a cloud-based, globally scalable, end-to-end automated, validation lifecycle management system (VLMS) from Archimedis Healthcare Private Limited (Archimedis), a family-owned pharmaceutical manufacturer based in India. The deal closed Aug. 24, 2018.

www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. (PRNewsFoto/Deloitte)" alt="As used in this document, "Deloitte" means Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. (PRNewsFoto/Deloitte)">

Launched in March 2017, QSpace is a VLMS that is designed to address IT quality and compliance, computerized system validation and Good X Practice requirements by digitizing the end-to-end validation process for IT systems in life sciences companies subject to U.S. and global regulatory requirements. Unlike many other solutions, QSpace integrates a number of aspects of IT quality and compliance within a single risk-based platform customized for life sciences organizations. It uses lean processes and system-induced controls to help reduce human errors and create greater enterprise-wide collaboration opportunities. QSpace's powerful analytics provide near real-time insights into critical performance indicators across the validation lifecycle, creating greater efficiencies that can help reduce compliance costs.

"QSpace enables us to help our clients disrupt the marketplace with a more agile, leaner and standardized VLMS," said Chuck Saia, CEO, Deloitte Risk and Financial Advisory, Deloitte & Touche LLP. "This innovative platform allows CIOs, CQOs and their teams in life sciences, regulatory compliance, and IT quality to embrace the complexity of validation lifecycle management."

Monica O'Reilly, Deloitte Risk and Financial Advisory principal and leader of its regulatory and operational risk practice, Deloitte & Touche LLP, added, "We know executives at leading organizations in the pharmaceutical, medical device, contract research, contract manufacturing and distribution sectors want to improve IT quality and compliance efforts as part of broader compliance modernization initiatives. QSpace enables that transformation for IT operations, compliance and risk management, while also freeing up resources for organizations to focus more on the business of innovating for the benefit of customers and patients."

About Deloitte US
The subsidiaries of Deloitte LLP provide industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including more than 85 percent of the Fortune 500 and more than 6,000 private and middle market companies. Our people work across more than 20 industry sectors to make an impact that matters — delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthy society. We are proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. 

Contact

Shelley Pfaendler


Public Relations


Deloitte LLP


+1 212-492-4484


spfaendler@deloitte.com

As used in this document, "Deloitte" means Deloitte & Touche LLP, a subsidiary of Deloitte LLP. Please see http://www.deloitte.com/us/about for a detailed description of our legal structure. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/deloitte-expands-life-sciences-solutions-suite-with-acquisition-of-qspace-it-quality-and-compliance-validation-technology-300702400.html

SOURCE Deloitte

View Comments and Join the Discussion!